Tci Wealth Advisors, Inc. Precision Biosciences Inc Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$0.97 - $45.0 $97 - $4,500	-100 Reduced 20.0%	400 $0
Q2 2022 Jul 19, 2022	SELL	$1.15 - $3.34 $1,087 - $3,159	-946 Reduced 65.42%	500 $1,000
Q1 2022 Apr 29, 2022	BUY	$2.96 - $7.76 $2,800 - $7,340	946 Added 189.2%	1,446 $5,000
Q4 2020 Jan 21, 2021	SELL	$5.98 - $12.47 $4,186 - $8,729	-700 Reduced 58.33%	500 $4,000
Q2 2020 Jul 20, 2020	SELL	$4.66 - $8.7 $466 - $869	-100 Reduced 7.69%	1,200 $10,000
Q1 2020 Apr 14, 2020	BUY	$5.05 - $15.01 $3,535 - $10,507	700 Added 116.67%	1,300 $8,000
Q3 2019 Oct 17, 2019	BUY	$8.03 - $14.82 $4,818 - $8,892	600 New	600 $5,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.